Cobalt chloride and roxadustat are hypoxia mimetics that increase erythropoietin production and can treat anemia by inhibiting PH3 [65,69,70], although they can also suppress other PHs (depending on the dose). The gene discussed is EPO; the disease is Pallister-Hall syndrome.